Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/26/15 → 1/26/21 |
Funding
- PPD Development (Prot #CC-10004-BCT-002 // Prot #CC-10004-BCT-002)
- Celgene Corporation (Prot #CC-10004-BCT-002 // Prot #CC-10004-BCT-002)
Prot #CC-10004-BCT-002: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group Study, followed by an Active-Treatment Phase to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Subjects with Active
- Brown Jr, Calvin R (PD/PI)
Project: Research project